BridgeBio Pharma, Inc. Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BridgeBio Pharma, Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
  • BridgeBio Pharma, Inc. Interest Expense for the quarter ending June 30, 2024 was $22.9M, a 11.4% increase year-over-year.
  • BridgeBio Pharma, Inc. Interest Expense for the twelve months ending June 30, 2024 was $87M, a 8.01% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2023 was $81.3M, a 1.06% increase from 2022.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2022 was $80.4M, a 72% increase from 2021.
  • BridgeBio Pharma, Inc. annual Interest Expense for 2021 was $46.8M, a 27.6% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $81.3M +$851K +1.06% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $80.4M +$33.7M +72% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $46.8M +$10.1M +27.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $36.7M +$27.9M +318% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $8.77M +$6.22M +244% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $2.55M -$10.5M -80.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $13M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.